INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 99 filers reported holding INTERSECT ENT INC in Q2 2016. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $647,000 | +20.0% | 25,977 | +9.7% | 0.03% | +3.2% |
Q2 2019 | $539,000 | +1.5% | 23,677 | +25.5% | 0.03% | -8.8% |
Q4 2018 | $531,000 | -58.9% | 18,860 | -58.1% | 0.03% | -42.4% |
Q3 2018 | $1,292,000 | +27.0% | 44,963 | +65.5% | 0.06% | +43.9% |
Q2 2018 | $1,017,000 | +27.9% | 27,163 | +34.2% | 0.04% | +28.1% |
Q1 2018 | $795,000 | -42.8% | 20,242 | -52.9% | 0.03% | -48.4% |
Q4 2017 | $1,391,000 | -41.9% | 42,942 | -44.1% | 0.06% | -49.2% |
Q3 2017 | $2,393,000 | +145.7% | 76,842 | +120.4% | 0.12% | +134.6% |
Q2 2017 | $974,000 | +274.6% | 34,864 | +129.4% | 0.05% | +333.3% |
Q1 2017 | $260,000 | -26.3% | 15,200 | -47.9% | 0.01% | -42.9% |
Q4 2016 | $353,000 | +57.6% | 29,200 | +68.1% | 0.02% | +90.9% |
Q2 2016 | $224,000 | -53.1% | 17,372 | -31.0% | 0.01% | -47.6% |
Q1 2016 | $478,000 | +30.6% | 25,172 | +60.8% | 0.02% | +50.0% |
Q3 2015 | $366,000 | -32.6% | 15,659 | -17.5% | 0.01% | -22.2% |
Q2 2015 | $543,000 | – | 18,990 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |